Women's Cancer Research Foundation

The Way Forward Is Clearer, Together.

The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.

Common Analgesics and Ovarian Cancer Survival: The Ovarian Cancer Prognosis and Lifestyle

Women's Cancer Research Foundation

Apr 26
2 min

Common Analgesics and Ovarian Cancer Survival: The Ovarian Cancer Prognosis and Lifestyle

Ovarian cancer (OC) is a silent killer that often goes undetected until it reaches advanced stages.

0 comments

Long-term Pelvic Fracture and Overall Mortality Risk After Pelvic Cancer Radiation

Women's Cancer Research Foundation

Mar 20
1 min

Long-term Pelvic Fracture and Overall Mortality Risk After Pelvic Cancer Radiation

The association between pelvic radiation for the treatment of gynecologic cancers and subsequent risk for pelvic fractures has not been....

0 comments

Women's Cancer Research Foundation

Mar 9
1 min

Processed Foods and Cancer

Overly processed foods, including prepackaged soups, sauces, frozen pizza and ready-to-eat meals, may raise the risk of ....

0 comments

Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment

Women's Cancer Research Foundation

Mar 3
2 min

Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment

The association of tamoxifen use with the risk of endometrial cancer in premenopausal women with breast cancer remains controversial.

0 comments

Incomplete Cisplatin Regimens in Chemoradiation & Effect On Outcomes for Advanced Cervical Cancer

Women's Cancer Research Foundation

Feb 17
2 min

Incomplete Cisplatin Regimens in Chemoradiation & Effect On Outcomes for Advanced Cervical Cancer

Presumably, fewer chemotherapy cycles should adversely impact patient prognosis, and this question was addressed in a recent article in....

0 comments

The Risks of Cancer in Older Women with BRCA Pathogenic Variants: How Far Have We Come?

Women's Cancer Research Foundation

Feb 3
2 min

The Risks of Cancer in Older Women with BRCA Pathogenic Variants: How Far Have We Come?

In a recent study, investigators estimated the cumulative risks of all cancers in women from 50 to 75 years of age who were diagnosed with..

0 comments